Prev：PGAM5 interacts with and maintains BNIP3 to license cancer-associated muscle wasting(A21010-14.3)
Next：pH sensitive peptide functionalized nanoparticles for co-delivery of erlotinib and DAPT to restrict the progress of triple negative breast cancer(A21020-3)
